A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/1999
10/14/1999	CA2325523A1 Prodrugs of phosphorous-containing pharmaceuticals
10/14/1999	CA2325339A1 Dadd, death activator death domain protein
10/14/1999	CA2324984A1 Secreted proteins and polynucleotides encoding them
10/14/1999	CA2324976A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof
10/14/1999	CA2324381A1 An integrin heterodimer and a subunit thereof
10/13/1999	EP0949245A1 Process for alkylating hindered sulfonamides
10/13/1999	EP0948620A2 Secreted proteins and polynucleotides encoding them
10/13/1999	EP0948544A1 Monovalent antibody fragments
10/13/1999	EP0948541A2 Analogs of parathyroid hormone
10/13/1999	EP0948510A1 Immunostimulatory nucleic acid molecules
10/13/1999	EP0948496A2 Substituted pyrimidinone and pyridone compounds and methods of use
10/13/1999	EP0948495A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
10/13/1999	EP0948493A1 Indene inhibitors of cox-2
10/13/1999	EP0948489A1 Piperazine compounds as inhibitors of mmp or tnf
10/13/1999	EP0948257A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
10/13/1999	EP0936912A4 Inhibitors of cysteine protease
10/13/1999	CN1231676A Parathyroid hormone analogues for the treatment of osteoporosis
10/13/1999	CN1231662A Quinazoline derivatives and pharmaceutical compositions containing them
10/13/1999	CN1231611A Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha'
10/13/1999	CN1231189A Traditional Chinese medicine for promoting blood circulation by removing blood stasis
10/12/1999	US5965787 HLA-DRBI peptides with specific binding affinity for HLA-DQ molecules: prevention and treatment of rheumatoid arthritis
10/12/1999	US5965693 Isolated polynucleotides; diagnosis and treatment of autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disorder, viricides, bactericides, fungicides and anticarcinogenic agents
10/12/1999	US5965583 Substituted imidazoles useful in the treatment of inflammatory disease
10/12/1999	US5965564 Enantiomerically pure hydroxylated xanthine compounds
10/12/1999	US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents
10/12/1999	US5965420 A protein which stimulates cell proliferation; treatment of bone loss due to osteoporosis; treat adult respiratory disease syndrome, parkinson'disease, huntington's disease; antiarthritic/anticarcinogenic agents; antiallergens
10/12/1999	US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999	US5965403 Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
10/12/1999	US5965397 Protein factor, cytokines, lymphokines, interferons, and interleukins, and colony stimulating factors; treatment of osteoporosis, stimulating or bone growth, regeneration of nerve and brain tissue, alzheimer/huntington disease's
10/12/1999	US5965388 Isolated polynucleotides; diagnosis and treatment autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disease; viricides, bactericides and fungicides; anticarcinogenic agents
10/08/1999	CA2267844A1 Use of a combination of an osteoinductive protein and a dorsalizing factor for cartilage induction
10/07/1999	WO1999050658A2 Methods and compounds for modulating nuclear receptor activity
10/07/1999	WO1999050285A2 Production methods and uses of a retrovirus
10/07/1999	WO1999050282A2 Peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases
10/07/1999	WO1999050252A2 Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same
10/07/1999	WO1999050249A2 Pyrimidines and triazines as integrin antagonists
10/07/1999	WO1999050241A1 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
10/07/1999	WO1999049885A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions
10/07/1999	WO1999049874A1 Dextran formulations and method for treatment of inflammatory joint disorders
10/07/1999	WO1999040220A3 Method of screening therapeutic agents
10/07/1999	WO1999031128A3 Human tumor necrosis factor-r2-like proteins
10/07/1999	DE19814358A1 Verwendung von Alkylhydrogenfumaraten zur Behandlung von Psoriasis, psoriatischer Arthritis, Neurodermitis und Enteritis regionalis Crohn Use of alkyl hydrogen for the treatment of psoriasis, psoriatic arthritis, atopic dermatitis, and Crohn's disease
10/07/1999	CA2333927A1 Pyrimidines and triazines as integrin antagonists
10/07/1999	CA2324584A1 Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same
10/07/1999	CA2324511A1 Novel peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases
10/07/1999	CA2324441A1 Materials and methods relating to a novel retrovirus
10/07/1999	CA2324060A1 Methods and compounds for modulating nuclear receptor activity
10/06/1999	EP0947524A1 Novel peptides for the treatment of autoimmune diseases
10/06/1999	EP0946728A1 Bone stimulating factor
10/06/1999	EP0946722A1 Human apoptosis-related calcium-binding protein
10/06/1999	EP0946587A2 New amide compounds
10/06/1999	EP0946585A1 Steroids substituted in position 11, method of preparation, application as medicines and pharmaceutical compositions containing them
10/06/1999	EP0946562A1 PYRROLO 3,4-$i(D)]PYRIMIDINONE DERIVATIVES AND THEIR USE AS MEDICAMENTS
10/06/1999	EP0946557A1 A-1-adenosine receptor antagonists
10/06/1999	EP0946541A1 Quinolines and their therapeutic use
10/06/1999	EP0946512A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/06/1999	EP0946502A1 Sulfonamide interleukin-beta converting enzyme inhibitors
10/06/1999	EP0946501A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
10/06/1999	EP0946182A1 17$g(a)-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT
10/06/1999	EP0946180A1 Method for stimulating bone formation
10/06/1999	EP0946165A1 Integrin antagonists
10/06/1999	EP0946164A1 Integrin antagonists
10/06/1999	CN1230955A Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
10/06/1999	CN1230948A Pyranoindole and carbazole inhibitors of COX-2
10/06/1999	CN1230892A Use of proteins as agents against autoimmune diseases
10/06/1999	CN1230402A Production of composite preparation of bone morphogenesis protein and collagen particle
10/05/1999	US5962707 19-nor-vitamin D3 compounds with calcemic activity
10/05/1999	US5962532 Therapeutic method with capsaicin and capsaicin analogues
10/05/1999	US5962475 Osteoporosis, restenosis, breast cancer
10/05/1999	US5962471 Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids
10/05/1999	US5962411 Human growth hormone variants and methods of administering same
10/05/1999	US5962021 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
09/1999
09/30/1999	WO1999049858A1 Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis
09/30/1999	WO1999049027A1 Methods for prevention and treatment of cancer
09/30/1999	WO1999048925A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses
09/30/1999	WO1999048910A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease
09/30/1999	WO1999048881A1 Metalloproteinase inhibitors
09/30/1999	WO1999048868A2 Heterocyclic classes of compounds for the modulating tyrosine protein kinase
09/30/1999	WO1999048523A2 Antagonists of the inflammatory mediator oncostatin m (osm)
09/30/1999	WO1999048495A1 Benzoates derivatives for inhibiting angiogenesis
09/30/1999	WO1999035246A9 Novel steroid-activated nuclear receptors and uses therefor
09/30/1999	WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
09/30/1999	CA2325935A1 Heterocyclic families of compounds for the modulation of tyrosine protein kinase
09/30/1999	CA2325585A1 Inflammatory mediator antagonists
09/30/1999	CA2324347A1 Benzoates derivatives for inhibiting angiogenesis
09/30/1999	CA2324340A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses
09/30/1999	CA2323782A1 Methods for prevention and treatment of cancer
09/30/1999	CA2323063A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease
09/29/1999	EP0944720A1 Adaptor protein frs2 and related products and methods
09/29/1999	EP0944645A1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME
09/29/1999	EP0944630A1 Xanthines and their therapeutic use
09/29/1999	EP0944619A1 Novel integrin receptor antagonists
09/29/1999	EP0944616A1 Bicyclic aryl carboxamides and their therapeutic use
09/29/1999	EP0944597A1 Metalloproteinase inhibitors
09/29/1999	EP0944592A1 Vitamin d3 derivatives
09/29/1999	EP0944391A1 Use of equilenin as an antioxidant
09/29/1999	EP0944390A1 USE OF 17$g(b)-DIHYDROEQUILENIN AS AN ANTIOXIDANT
09/29/1999	EP0944312A1 Compositions and methods for stimulating bone growth
09/29/1999	CN1230196A Modified aminoacids, pharmaceuticals containing these compounds and method for their prodn.
09/29/1999	CN1230174A Benzamidine derivatives and use thereof as medicaments with LTB4-antagonistic effect

1 ... 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 ... 820